Germany Facial Injectable Market Size & Outlook, 2025-2030

The facial injectable market in Germany is expected to reach a projected revenue of US$ 1,553.3 million by 2030. A compound annual growth rate of 11.2% is expected of Germany facial injectable market from 2025 to 2030.
Revenue, 2024 (US$M)
$828.7
Forecast, 2030 (US$M)
$1,553.3
CAGR, 2025 - 2030
11.2%
Report Coverage
Germany

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Germany facial injectable market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Germany facial injectable market highlights

  • The Germany facial injectable market generated a revenue of USD 828.7 million in 2024 and is expected to reach USD 1,553.3 million by 2030.
  • The Germany market is expected to grow at a CAGR of 11.2% from 2025 to 2030.
  • In terms of segment, botulinum toxin type a was the largest revenue generating product in 2024.
  • HA is the most lucrative product segment registering the fastest growth during the forecast period.


Facial injectable market data book summary

Market revenue in 2024USD 828.7 million
Market revenue in 2030USD 1,553.3 million
Growth rate11.2% (CAGR from 2025 to 2030)
Largest segmentBotulinum toxin type a
Fastest growing segmentHA
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCollagen, Botulinum Toxin Type A, HA, CaHA, PLLA


Other key industry trends

  • In terms of revenue, Germany accounted for 6.6% of the global facial injectable market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany facial injectable market is projected to lead the regional market in terms of revenue in 2030.
  • France is the fastest growing regional market in Europe and is projected to reach USD 1,024.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Facial Injectable Market Companies

Name Profile # Employees HQ Website
Galderma View profile 10001+ Lausanne, Vaud, Switzerland, Europe http://www.galderma.com
Medytox View profile 501-1000 Seoul, Seoul-t'ukpyolsi, South Korea, Asia http://www.medytox.com/page/company_en?site_id=en
Sinclair Pharma plc View profile 501-1000 London, England, United Kingdom, Europe http://www.sinclairpharma.com/
Merz Pharma View profile 5001-10000 Deutsch, Sachsen, Germany, Europe http://www.merz.com
Revance Therapeutics Inc View profile 597 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 https://www.revance.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com

Germany facial injectable market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to facial injectable market will help companies and investors design strategic landscapes.


Botulinum toxin type a was the largest segment with a revenue share of 54.92% in 2024. Horizon Databook has segmented the Germany facial injectable market based on collagen, botulinum toxin type a, ha, caha, plla covering the revenue growth of each sub-segment from 2018 to 2030.


Germany's Facial Injectable Market dominated the European region and is experiencing significant growth, driven by technological advancements, product innovation, and increasing demand for non-invasive aesthetic treatments. For instance, in January 2025, Merz Aesthetics, a Germany-based company, launched Ultherapy PRIME across Europe, the Middle East, and Africa, enhancing its portfolio of non-invasive skin-lifting solutions.

This development reflects a growing consumer preference for minimally invasive procedures that offer effective skin rejuvenation with minimal downtime. Additionally, Merz Aesthetics' presentation of six abstracts at the 2025 International Master Course on Aging Science (IMCAS) World Congress highlights Germany's strong role in advancing regenerative aesthetics.

With continuous innovation in dermal fillers and botulinum toxin treatments, alongside rising awareness and adoption of aesthetic procedures, Germany remains a key market for facial injectables, with demand expected to grow as new technologies emerge.

Reasons to subscribe to Germany facial injectable market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Germany facial injectable market databook

  • Our clientele includes a mix of facial injectable market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Germany facial injectable market , including forecasts for subscribers. This country databook contains high-level insights into Germany facial injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Germany Product - Facial Injectable Market size, 2024 - 2030 (US$M)

Germany Facial Injectable Market Outlook Share, 2024 & 2030 (US$M)

Germany Product - Facial Injectable Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online